Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?

Journal Title: Journal of Urological Surgery - Year 2019, Vol 6, Issue 2

Abstract

Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the treatment of OAB. However, antimuscarinics are known to have low persistence rates in clinical practice. Mirabegron is an oral β3-adrenoreceptor agonist which has emerged as an alternative to antimuscarinics for managing OAB. Overall, mirabegron has similar clinical efficacy to antimuscarinics and is superior to placebo. Mirabegron has been generally well tolerated in both interventional and non-interventional studies. Persistence has been shown to be higher with mirabegron than with antimuscarinics in realworld studies. Increased blood pressure is associated with mirabegron and therefore its use is contraindicated in patients with severe uncontrolled hypertension. However, a low rate of treatment cessation due to cardiovascular issues has been noted in clinical trials. Mirabegron’s utility in the elderly patient population has been well supported with promising efficacy and safety outcomes. New data from a prospective placebo-controlled randomized trial in older OAB patients is expected to be published soon. Mirabegron does not interfere with detrusor contractions during the emptying phase of the micturition cycle and hence lacks any significant effect on post-void residual volume. Mirabegron can be combined with antimuscarinics to synergize clinical effectiveness. Overall, mirabegron represents a well-tolerated and effective medical treatment option for OAB. Mirabegron could be used as an alternative to antimuscarinics, especially in patients who do not improve with antimuscarinics and/or experience bothersome side effects for whom anticholinergic load may be a relevant consideration.

Authors and Affiliations

Ömer Acar, Mustafa Levent Erton, Tufan Tarcan

Keywords

Related Articles

An Overview of the Advantages of Digital Flexible Ureteroscopes. A Review by Young Academic Urologists Endourology and Urolithiasis Working Party of the European Association of Urology

Endoscopic technology is the cream of the crop for the urinary tract endoscopic procedures in our modern era of surgery. The idea of this review was to evaluate different characteristics of fiberoptic (FO), reusable digi...

Laparoscopic Transperitoneal Simple, Radical and Partial Nephrectomy: A Single Center Experience

Objective: To present our initial experience on laparoscopic transperitoneal nephrectomies and to report the perioperative and postoperative outcomes in patients with kidney tumor. Materials and Methods: We retrospectiv...

Urothelial Carcinoma of the Upper Urinary Tract That Becomes Resectable After Neoadjuvant Chemotherapy: A Case Report and Review of the Literature

Upper tract urothelial carcinoma (UTUC) is less common than bladder cancer, but its incidence is increasing. Neoadjuvant chemotherapy (NAC) has been the treatment focus for locally invasive and high-grade UTUC. Herein, w...

Epidemiologic Analysis of Urological Cases Admitted to an Emergency Department of a Tertiary Care Center

Objective: We evaluated emergency urology patients admitted to the emergency department of our hospital in terms of demographic and epidemiological characteristics, in order to contribute to the relevant data of our cou...

A Rare Case of Incidentally Detected Fused Supernumerary Kidney

Congenital renal anomalies are one of the most common congenital malformations. Supernumerary kidney is rare among these anomalies. A 78-year-old female patient, without urinary system complaints, was screened by abdomin...

Download PDF file
  • EP ID EP48971
  • DOI 10.4274/jus.galenos.2019.2533
  • Views 377
  • Downloads 0

How To Cite

Ömer Acar, Mustafa Levent Erton, Tufan Tarcan (2019). Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?. Journal of Urological Surgery, 6(2), -. https://europub.co.uk/articles/-A-48971